Markets.com Logo

ADXS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0532$
  • Previous Close
    0.0532$
  • 52 Week Change
    0.76$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.02$ - 0.777$
  • Dividend Per Share
    --
  • Market cap
    2 257 K$
  • EPS
    0
  • Beta
    --
  • Volume
    --

About

ADXS.US was the stock ticker symbol for Advaxis, Inc., a biotechnology company focused on developing cancer immunotherapies. Advaxis was based in Princeton, New Jersey, and their primary technology platform was based on Listeria monocytogenes (Lm)-based antigen delivery. The company aimed to harness the power of the body's immune system to target and destroy cancer cells. However, Advaxis struggled financially and operationally. Trading of ADXS.US was ultimately suspended, and the company entered bankruptcy. The stock is no longer actively traded on major exchanges.

Fed's New Era: Warsh Signals Caution Amid Inflation and Market Jitters

Emma Rose|--

Storage Chip Sector Rebound: Is AI Sustaining the Cycle?

Sophia Claire|--

New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations

Emma Rose|--

Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics

Sophia Claire|--

US Stock Market Volatility Surges as Trading Logic Breaks Down

Emma Rose|--

2026 World Cup: A Watershed Moment for Predictive Markets and a Boost for DraftKings

Emma Rose|--

Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain

Sophia Claire|--

Factors

Clinical Trial Results: Positive data from Advaxis' clinical trials often leads to increased investor confidence and higher stock prices. Conversely, negative or inconclusive results can cause the price to fall.

Regulatory Approvals: FDA approvals for Advaxis' immunotherapy drugs are major catalysts that typically drive significant stock price increases. Rejections or delays can negatively impact the stock.

Partnerships and Collaborations: Strategic partnerships with larger pharmaceutical companies or research institutions can boost investor sentiment and increase the stock price due to validation and potential funding.

Financial Performance: Advaxis' cash position, burn rate, and ability to secure funding influence investor confidence. Concerns about financial stability can depress the stock price.

Market Sentiment: Overall market conditions and investor appetite for risk, particularly in the biotech sector, can affect ADXS.US. Positive market sentiment tends to lift the stock.

Competition: The competitive landscape in the immunotherapy space impacts investor perception of Advaxis' potential. Strong competition can pressure the stock price.

News and Media Coverage: News articles, analyst ratings, and social media discussions can influence investor behavior and affect the stock price.

People Also Watch

Latest news

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Sophia Claire|--

Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy

Emma Rose|--

Global Market Snapshot: Key Events and Analysis of Financial Markets

Liam James|--

Latest Education Articles

Most Volatile Forex Pairs: What Traders Should Know

Most Volatile Forex Pairs: What Traders Should Know

Julian Parker|--
What Happens on the Day of an IPO?

What Happens on the Day of an IPO?

Julian Parker|--
10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Julian Parker|--
Recommended Topics